PRLD – prelude therapeutics incorporated (US:NASDAQ)
Stock Stats
News
Down -39.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Prelude Therapeutics (PRLD) [Yahoo! Finance]
Prelude Therapeutics Incorporated (NASDAQ: PRLD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Prelude Therapeutics Incorporated (NASDAQ: PRLD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Form 10-Q Prelude Therapeutics For: Sep 30
Form 8-K Prelude Therapeutics For: Nov 06
Form 8-K Prelude Therapeutics For: Oct 24
Form 4 Prelude Therapeutics For: Oct 04 Filed by: Huang Jane
Form 8-K Prelude Therapeutics For: Sep 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.